Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reno Debets

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Human Gene Therapy Methods|August 9, 2012
Magnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cellsCoen Govers, Cor Berrevoets, Elike Treffers-Westerlaken, et al.
Journal for Immunotherapy of Cancer|April 21, 2016
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientImran Siddiqui, Marco Erreni, Mandy van Brakel, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 12, 2008
Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapyRalph Willemsen, Patrick Chames, Erik Schooten, et al.
Molecular Immunology|March 23, 2010
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificityNadine Pouw, Elike Treffers-Westerlaken, Anna Mondino, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
Retroviral Transduction of Human Primary T Cells Followed by Real-Time T-Cell-Mediated Cancer Cell Cytolysis AnalysisAnne Rahbech, Reno Debets, Per Thor Straten, et al.
Cancer Research|December 7, 2007
An oncolytic adenovirus redirected with a tumor-specific T-cell receptorZsolt Sebestyen, Jeroen de Vrij, Maria Magnusson, et al.
Expert Opinion on Biological Therapy|February 12, 2010
T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studiesMiriam Coccoris, Trudy Straetemans, Coen Govers, et al.
Trends in Molecular Medicine|May 23, 2012
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foeDavid E Gilham, Reno Debets, Martin Pule, et al.
The Journal of Gene Medicine|May 2, 2007
Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopesNadine M C Pouw, Elike J Westerlaken, Ralph A Willemsen, et al.
Trends in Immunology|October 13, 2018
Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful AlliesDora Hammerl, Dietmar Rieder, John W M Martens, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Human Gene Therapy Methods|August 9, 2012
Magnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cellsCoen Govers, Cor Berrevoets, Elike Treffers-Westerlaken, et al.
Journal for Immunotherapy of Cancer|April 21, 2016
Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradientImran Siddiqui, Marco Erreni, Mandy van Brakel, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 12, 2008
Selection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapyRalph Willemsen, Patrick Chames, Erik Schooten, et al.
Molecular Immunology|March 23, 2010
TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificityNadine Pouw, Elike Treffers-Westerlaken, Anna Mondino, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 9, 2023
Retroviral Transduction of Human Primary T Cells Followed by Real-Time T-Cell-Mediated Cancer Cell Cytolysis AnalysisAnne Rahbech, Reno Debets, Per Thor Straten, et al.
Cancer Research|December 7, 2007
An oncolytic adenovirus redirected with a tumor-specific T-cell receptorZsolt Sebestyen, Jeroen de Vrij, Maria Magnusson, et al.
Expert Opinion on Biological Therapy|February 12, 2010
T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studiesMiriam Coccoris, Trudy Straetemans, Coen Govers, et al.
Trends in Molecular Medicine|May 23, 2012
CAR-T cells and solid tumors: tuning T cells to challenge an inveterate foeDavid E Gilham, Reno Debets, Martin Pule, et al.
The Journal of Gene Medicine|May 2, 2007
Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopesNadine M C Pouw, Elike J Westerlaken, Ralph A Willemsen, et al.
Trends in Immunology|October 13, 2018
Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful AlliesDora Hammerl, Dietmar Rieder, John W M Martens, et al.
Pageof 14